nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—liver cancer	0.641	1	CbGaD
Fingolimod—S1PR1—umbilical vein—liver cancer	0.0332	0.574	CbGeAlD
Fingolimod—S1PR5—liver—liver cancer	0.00547	0.0945	CbGeAlD
Fingolimod—CYP4F2—liver—liver cancer	0.00513	0.0886	CbGeAlD
Fingolimod—S1PR3—liver—liver cancer	0.00455	0.0786	CbGeAlD
Fingolimod—S1PR1—liver—liver cancer	0.00401	0.0693	CbGeAlD
Fingolimod—CYP4F12—liver—liver cancer	0.00381	0.0658	CbGeAlD
Fingolimod—Lymphopenia—Sorafenib—liver cancer	0.0032	0.0579	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Sorafenib—liver cancer	0.00296	0.0535	CcSEcCtD
Fingolimod—Eczema—Sorafenib—liver cancer	0.00132	0.0239	CcSEcCtD
Fingolimod—Lymphopenia—Epirubicin—liver cancer	0.00118	0.0214	CcSEcCtD
Fingolimod—Lymphopenia—Doxorubicin—liver cancer	0.00109	0.0198	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.00107	0.0194	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00105	0.019	CcSEcCtD
Fingolimod—Weight decreased—Sorafenib—liver cancer	0.000929	0.0168	CcSEcCtD
Fingolimod—Pneumonia—Sorafenib—liver cancer	0.000921	0.0167	CcSEcCtD
Fingolimod—Infestation—Sorafenib—liver cancer	0.000916	0.0166	CcSEcCtD
Fingolimod—Infestation NOS—Sorafenib—liver cancer	0.000916	0.0166	CcSEcCtD
Fingolimod—Connective tissue disorder—Sorafenib—liver cancer	0.000808	0.0146	CcSEcCtD
Fingolimod—Herpes zoster—Epirubicin—liver cancer	0.000804	0.0145	CcSEcCtD
Fingolimod—Cardiac disorder—Sorafenib—liver cancer	0.000763	0.0138	CcSEcCtD
Fingolimod—Angiopathy—Sorafenib—liver cancer	0.000746	0.0135	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—liver cancer	0.000744	0.0135	CcSEcCtD
Fingolimod—Mediastinal disorder—Sorafenib—liver cancer	0.000741	0.0134	CcSEcCtD
Fingolimod—Alopecia—Sorafenib—liver cancer	0.000727	0.0131	CcSEcCtD
Fingolimod—Mental disorder—Sorafenib—liver cancer	0.00072	0.013	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—liver cancer	0.000719	0.013	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—liver cancer	0.000665	0.012	CcSEcCtD
Fingolimod—CYP2E1—liver—liver cancer	0.000643	0.0111	CbGeAlD
Fingolimod—Leukopenia—Sorafenib—liver cancer	0.000641	0.0116	CcSEcCtD
Fingolimod—Cough—Sorafenib—liver cancer	0.000625	0.0113	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—liver cancer	0.000624	0.0113	CcSEcCtD
Fingolimod—Hypertension—Sorafenib—liver cancer	0.000618	0.0112	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000605	0.0109	CcSEcCtD
Fingolimod—Infection—Sorafenib—liver cancer	0.00058	0.0105	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—liver cancer	0.000577	0.0104	CcSEcCtD
Fingolimod—Nervous system disorder—Sorafenib—liver cancer	0.000573	0.0104	CcSEcCtD
Fingolimod—Skin disorder—Sorafenib—liver cancer	0.000567	0.0103	CcSEcCtD
Fingolimod—Dyspnoea—Sorafenib—liver cancer	0.000521	0.00942	CcSEcCtD
Fingolimod—CYP3A4—liver—liver cancer	0.000517	0.00893	CbGeAlD
Fingolimod—CYP2D6—liver—liver cancer	0.000509	0.00879	CbGeAlD
Fingolimod—Gastrointestinal disorder—Sorafenib—liver cancer	0.000504	0.00912	CcSEcCtD
Fingolimod—Fatigue—Sorafenib—liver cancer	0.000504	0.00911	CcSEcCtD
Fingolimod—Eczema—Epirubicin—liver cancer	0.000489	0.00884	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—liver cancer	0.000487	0.0088	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—liver cancer	0.000452	0.00818	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—liver cancer	0.00045	0.00814	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—liver cancer	0.000448	0.00811	CcSEcCtD
Fingolimod—Migraine—Epirubicin—liver cancer	0.000432	0.00782	CcSEcCtD
Fingolimod—Asthenia—Sorafenib—liver cancer	0.000419	0.00758	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—liver cancer	0.000418	0.00756	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—liver cancer	0.000415	0.0075	CcSEcCtD
Fingolimod—Pruritus—Sorafenib—liver cancer	0.000413	0.00748	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—liver cancer	0.000406	0.00734	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—liver cancer	0.0004	0.00724	CcSEcCtD
Fingolimod—Diarrhoea—Sorafenib—liver cancer	0.0004	0.00723	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000396	0.00716	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000387	0.00701	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—liver cancer	0.000386	0.00699	CcSEcCtD
Fingolimod—Dizziness—Sorafenib—liver cancer	0.000386	0.00699	CcSEcCtD
Fingolimod—Influenza—Epirubicin—liver cancer	0.00038	0.00687	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—liver cancer	0.000375	0.00679	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000366	0.00662	CcSEcCtD
Fingolimod—Headache—Sorafenib—liver cancer	0.000366	0.00662	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—liver cancer	0.000365	0.00661	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000358	0.00649	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—liver cancer	0.000351	0.00636	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—liver cancer	0.000343	0.00621	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—liver cancer	0.00034	0.00616	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—liver cancer	0.000338	0.00612	CcSEcCtD
Fingolimod—Infestation—Epirubicin—liver cancer	0.000338	0.00612	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—liver cancer	0.000338	0.00611	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—liver cancer	0.000318	0.00575	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—liver cancer	0.000318	0.00575	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—liver cancer	0.000315	0.0057	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—liver cancer	0.000313	0.00567	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—liver cancer	0.000313	0.00567	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—liver cancer	0.000309	0.0056	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—liver cancer	0.000299	0.0054	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—liver cancer	0.000294	0.00532	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—liver cancer	0.000286	0.00518	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—liver cancer	0.000284	0.00514	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—liver cancer	0.000282	0.0051	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—liver cancer	0.000276	0.005	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—liver cancer	0.000276	0.00499	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—liver cancer	0.000274	0.00495	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—liver cancer	0.000269	0.00486	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—liver cancer	0.000266	0.00482	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—liver cancer	0.000263	0.00475	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—liver cancer	0.000261	0.00472	CcSEcCtD
Fingolimod—Back pain—Epirubicin—liver cancer	0.000256	0.00463	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—liver cancer	0.000255	0.00462	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—liver cancer	0.000253	0.00458	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—liver cancer	0.000249	0.00451	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—liver cancer	0.000248	0.0045	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—liver cancer	0.000246	0.00446	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—liver cancer	0.000237	0.00428	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—liver cancer	0.000237	0.00428	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—liver cancer	0.000234	0.00423	CcSEcCtD
Fingolimod—Cough—Epirubicin—liver cancer	0.000231	0.00418	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—liver cancer	0.000231	0.00417	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—liver cancer	0.000228	0.00413	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000224	0.00405	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—liver cancer	0.000219	0.00396	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—liver cancer	0.000216	0.00391	CcSEcCtD
Fingolimod—Infection—Epirubicin—liver cancer	0.000214	0.00388	CcSEcCtD
Fingolimod—Cough—Doxorubicin—liver cancer	0.000214	0.00386	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—liver cancer	0.000212	0.00383	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—liver cancer	0.000211	0.00382	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—liver cancer	0.00021	0.00379	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000207	0.00374	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—liver cancer	0.000202	0.00365	CcSEcCtD
Fingolimod—Infection—Doxorubicin—liver cancer	0.000198	0.00359	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—liver cancer	0.000196	0.00354	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—liver cancer	0.000194	0.00351	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—liver cancer	0.000194	0.00351	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—liver cancer	0.000192	0.00348	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—liver cancer	0.000187	0.00338	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—liver cancer	0.000186	0.00337	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—liver cancer	0.000186	0.00337	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—liver cancer	0.000179	0.00325	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—liver cancer	0.000178	0.00322	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000172	0.00312	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—liver cancer	0.000172	0.00312	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—liver cancer	0.000155	0.0028	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—liver cancer	0.000153	0.00276	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—liver cancer	0.000148	0.00267	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—liver cancer	0.000143	0.00259	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—liver cancer	0.000143	0.00258	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—liver cancer	0.000141	0.00256	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—liver cancer	0.000137	0.00247	CcSEcCtD
Fingolimod—Headache—Epirubicin—liver cancer	0.000135	0.00245	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—liver cancer	0.000132	0.00239	CcSEcCtD
Fingolimod—Headache—Doxorubicin—liver cancer	0.000125	0.00226	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PIK3CD—liver cancer	5.3e-05	0.000215	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CB—liver cancer	5.28e-05	0.000215	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MTOR—liver cancer	5.28e-05	0.000215	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—liver cancer	5.25e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—liver cancer	5.25e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—liver cancer	5.25e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SERPINE1—liver cancer	5.24e-05	0.000213	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TAT—liver cancer	5.21e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RAF1—liver cancer	5.21e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RAF1—liver cancer	5.21e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—liver cancer	5.18e-05	0.000211	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MTOR—liver cancer	5.08e-05	0.000207	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CB—liver cancer	5.08e-05	0.000207	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MTOR—liver cancer	5.08e-05	0.000207	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CB—liver cancer	5.08e-05	0.000207	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.05e-05	0.000205	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—liver cancer	5.04e-05	0.000205	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—BRAF—liver cancer	5.01e-05	0.000204	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	4.98e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1B—liver cancer	4.96e-05	0.000201	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—liver cancer	4.9e-05	0.000199	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CB—liver cancer	4.89e-05	0.000198	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—liver cancer	4.86e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—liver cancer	4.85e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—liver cancer	4.85e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—liver cancer	4.85e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—liver cancer	4.83e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—liver cancer	4.77e-05	0.000194	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—liver cancer	4.77e-05	0.000194	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—liver cancer	4.76e-05	0.000194	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RAF1—liver cancer	4.73e-05	0.000192	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—liver cancer	4.73e-05	0.000192	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—liver cancer	4.72e-05	0.000192	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—liver cancer	4.72e-05	0.000192	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JUN—liver cancer	4.72e-05	0.000192	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CD—liver cancer	4.69e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—liver cancer	4.68e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—liver cancer	4.68e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—liver cancer	4.68e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—liver cancer	4.67e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—liver cancer	4.67e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—liver cancer	4.65e-05	0.000189	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—liver cancer	4.65e-05	0.000189	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SERPINE1—liver cancer	4.64e-05	0.000188	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GGT1—liver cancer	4.63e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MTOR—liver cancer	4.62e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CB—liver cancer	4.62e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—liver cancer	4.59e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1A—liver cancer	4.57e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—liver cancer	4.55e-05	0.000185	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—liver cancer	4.55e-05	0.000185	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JUN—liver cancer	4.54e-05	0.000184	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JUN—liver cancer	4.54e-05	0.000184	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—liver cancer	4.51e-05	0.000183	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—liver cancer	4.51e-05	0.000183	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK8—liver cancer	4.46e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—liver cancer	4.45e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—liver cancer	4.42e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—liver cancer	4.42e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—liver cancer	4.41e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1A—liver cancer	4.4e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1A—liver cancer	4.4e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—liver cancer	4.33e-05	0.000176	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK8—liver cancer	4.3e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK8—liver cancer	4.3e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—liver cancer	4.29e-05	0.000174	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—liver cancer	4.29e-05	0.000174	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—liver cancer	4.29e-05	0.000174	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—liver cancer	4.25e-05	0.000172	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—liver cancer	4.24e-05	0.000172	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—liver cancer	4.22e-05	0.000171	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RAF1—liver cancer	4.18e-05	0.00017	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.16e-05	0.000169	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UGDH—liver cancer	4.15e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—liver cancer	4.13e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JUN—liver cancer	4.12e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—liver cancer	4.12e-05	0.000167	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.1e-05	0.000167	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—liver cancer	4.09e-05	0.000166	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MTOR—liver cancer	4.09e-05	0.000166	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CB—liver cancer	4.09e-05	0.000166	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—liver cancer	4.08e-05	0.000166	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—liver cancer	4.02e-05	0.000163	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—liver cancer	4.01e-05	0.000163	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—liver cancer	4e-05	0.000162	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—liver cancer	3.97e-05	0.000161	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—liver cancer	3.97e-05	0.000161	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—liver cancer	3.93e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—liver cancer	3.93e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK8—liver cancer	3.9e-05	0.000159	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EPT1—liver cancer	3.9e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—liver cancer	3.89e-05	0.000158	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—liver cancer	3.83e-05	0.000156	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—liver cancer	3.82e-05	0.000155	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—liver cancer	3.79e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—liver cancer	3.78e-05	0.000154	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	3.77e-05	0.000153	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—liver cancer	3.76e-05	0.000153	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—liver cancer	3.75e-05	0.000152	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TAT—liver cancer	3.7e-05	0.00015	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—liver cancer	3.66e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—liver cancer	3.65e-05	0.000148	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—liver cancer	3.65e-05	0.000148	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JUN—liver cancer	3.65e-05	0.000148	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—liver cancer	3.64e-05	0.000148	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—liver cancer	3.64e-05	0.000148	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.63e-05	0.000147	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—liver cancer	3.62e-05	0.000147	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—liver cancer	3.6e-05	0.000146	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.58e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—liver cancer	3.57e-05	0.000145	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—liver cancer	3.55e-05	0.000144	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CPT1B—liver cancer	3.54e-05	0.000144	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GLUL—liver cancer	3.54e-05	0.000144	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—liver cancer	3.54e-05	0.000144	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—liver cancer	3.5e-05	0.000142	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—liver cancer	3.47e-05	0.000141	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK8—liver cancer	3.45e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NR1H4—liver cancer	3.41e-05	0.000139	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—liver cancer	3.37e-05	0.000137	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—liver cancer	3.37e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA3—liver cancer	3.36e-05	0.000136	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—liver cancer	3.31e-05	0.000135	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—liver cancer	3.31e-05	0.000134	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—liver cancer	3.28e-05	0.000133	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—liver cancer	3.22e-05	0.000131	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—liver cancer	3.19e-05	0.00013	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—liver cancer	3.16e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—liver cancer	3.11e-05	0.000127	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—liver cancer	3.1e-05	0.000126	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—liver cancer	3.1e-05	0.000126	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA4—liver cancer	3.07e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—liver cancer	3.06e-05	0.000124	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—liver cancer	3e-05	0.000122	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—liver cancer	3e-05	0.000122	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA2—liver cancer	2.99e-05	0.000122	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—liver cancer	2.98e-05	0.000121	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—liver cancer	2.98e-05	0.000121	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—liver cancer	2.93e-05	0.000119	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—liver cancer	2.93e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA1—liver cancer	2.89e-05	0.000117	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—liver cancer	2.87e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—liver cancer	2.87e-05	0.000116	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAT2—liver cancer	2.85e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—liver cancer	2.85e-05	0.000116	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—liver cancer	2.83e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—liver cancer	2.81e-05	0.000114	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—liver cancer	2.74e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—liver cancer	2.74e-05	0.000111	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDOB—liver cancer	2.74e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—liver cancer	2.72e-05	0.000111	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UGDH—liver cancer	2.71e-05	0.00011	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—liver cancer	2.71e-05	0.00011	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—liver cancer	2.63e-05	0.000107	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CRABP1—liver cancer	2.61e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—liver cancer	2.6e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EPT1—liver cancer	2.55e-05	0.000104	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—liver cancer	2.53e-05	0.000103	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—liver cancer	2.53e-05	0.000103	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CPT1B—liver cancer	2.51e-05	0.000102	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GLUL—liver cancer	2.51e-05	0.000102	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—liver cancer	2.49e-05	0.000101	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—liver cancer	2.49e-05	0.000101	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—liver cancer	2.43e-05	9.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NR1H4—liver cancer	2.42e-05	9.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TAT—liver cancer	2.42e-05	9.82e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—liver cancer	2.41e-05	9.79e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA3—liver cancer	2.38e-05	9.68e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—liver cancer	2.3e-05	9.36e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—liver cancer	2.3e-05	9.34e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPGDS—liver cancer	2.28e-05	9.27e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—liver cancer	2.21e-05	8.96e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA4—liver cancer	2.18e-05	8.85e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA2—liver cancer	2.12e-05	8.62e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA1—liver cancer	2.05e-05	8.32e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—liver cancer	2.03e-05	8.26e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSMA4—liver cancer	2.03e-05	8.26e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSMD10—liver cancer	2.03e-05	8.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAT2—liver cancer	2.03e-05	8.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GOT2—liver cancer	1.98e-05	8.04e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDOB—liver cancer	1.94e-05	7.89e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CRABP1—liver cancer	1.85e-05	7.53e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYCS—liver cancer	1.74e-05	7.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GGT1—liver cancer	1.71e-05	6.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GOT1—liver cancer	1.71e-05	6.94e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CPT1B—liver cancer	1.64e-05	6.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GLUL—liver cancer	1.64e-05	6.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPGDS—liver cancer	1.62e-05	6.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NR1H4—liver cancer	1.58e-05	6.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA3—liver cancer	1.56e-05	6.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—liver cancer	1.53e-05	6.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—liver cancer	1.51e-05	6.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSMA4—liver cancer	1.44e-05	5.86e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSMD10—liver cancer	1.44e-05	5.86e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA4—liver cancer	1.42e-05	5.79e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—liver cancer	1.41e-05	5.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GOT2—liver cancer	1.4e-05	5.7e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA2—liver cancer	1.39e-05	5.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA1—liver cancer	1.34e-05	5.44e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A1—liver cancer	1.34e-05	5.43e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAT2—liver cancer	1.32e-05	5.38e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2E1—liver cancer	1.32e-05	5.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDOB—liver cancer	1.27e-05	5.16e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—liver cancer	1.25e-05	5.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYCS—liver cancer	1.23e-05	5.02e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARA—liver cancer	1.22e-05	4.97e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GGT1—liver cancer	1.21e-05	4.92e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GOT1—liver cancer	1.21e-05	4.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CRABP1—liver cancer	1.21e-05	4.92e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—liver cancer	1.09e-05	4.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—liver cancer	1.07e-05	4.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGDS—liver cancer	1.06e-05	4.3e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—liver cancer	1.05e-05	4.25e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—liver cancer	1.01e-05	4.1e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—liver cancer	1e-05	4.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A1—liver cancer	9.48e-06	3.85e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSMA4—liver cancer	9.44e-06	3.83e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSMD10—liver cancer	9.44e-06	3.83e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—liver cancer	9.2e-06	3.74e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GOT2—liver cancer	9.18e-06	3.73e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—liver cancer	9.08e-06	3.69e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—liver cancer	8.84e-06	3.59e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARA—liver cancer	8.67e-06	3.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2E1—liver cancer	8.63e-06	3.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYCS—liver cancer	8.07e-06	3.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—liver cancer	8.02e-06	3.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GGT1—liver cancer	7.92e-06	3.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GOT1—liver cancer	7.92e-06	3.22e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—liver cancer	7.43e-06	3.02e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—liver cancer	7.17e-06	2.91e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—liver cancer	7.12e-06	2.89e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—liver cancer	7.02e-06	2.85e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—liver cancer	6.54e-06	2.66e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—liver cancer	6.53e-06	2.65e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—liver cancer	6.45e-06	2.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A1—liver cancer	6.2e-06	2.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—liver cancer	5.78e-06	2.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—liver cancer	5.69e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARA—liver cancer	5.67e-06	2.3e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—liver cancer	4.89e-06	1.99e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—liver cancer	4.86e-06	1.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—liver cancer	4.69e-06	1.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—liver cancer	4.27e-06	1.73e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—liver cancer	4.21e-06	1.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—liver cancer	3.99e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—liver cancer	3.72e-06	1.51e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—liver cancer	3.47e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—liver cancer	2.83e-06	1.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—liver cancer	2.27e-06	9.22e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—liver cancer	1.85e-06	7.53e-06	CbGpPWpGaD
